Trial Profile
Multi-centre, Randomized, Double-blind, Placebo-Controlled Pilot Safety and Efficacy Study of 8 Weeks of Treatment with DFD-07 for Actinic Keratosis of the Face and Scalp
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2020
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors Promius Pharma
- 02 Aug 2016 Status changed from recruiting to completed.
- 25 Nov 2015 New trial record